Long-Term Impact of Systolic Blood Pressure and Glycemia on the Development of Microalbuminuria in Essential Hypertension

No abstract is available for this paper.

• Publication year

  2005

• Venue

  HYPERTENSION

• Publication date

  2005-06-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1161/01.HYP.0000167151.52825.11PMID 15897369
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• 2007 Guidelines for the Management of Arterial Hypertension: The Task Force for the Management of Arterial Hypertension of the European Society of Hypertension (ESH) and of the European Society of Cardiology (ESC)

  2007cited by this paper
• Does albuminuria predict cardiovascular outcome on treatment with losartan versus atenolol in hypertension with left ventricular hypertrophy? A LIFE substudy

  2004cited by this paper
• Microalbuminuria as an intermediate endpoint in essential hypertension: evidence is coming.

  2004cited by this paper
• 2003 European Society of Hypertension-European Society of Cardiology guidelines for the management of arterial hypertension.

  2003cited by this paper
• The Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure: the JNC 7 report.

  2003cited by this paper
• Microalbuminuria and hypertension with focus on type 1 and type 2 diabetes *

  2003cited by this paper
• Seventh report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure.

  2003cited by this paper
• European Society of Hypertension – European Society of Cardiology guidelines for the management of arterial hypertension

  2003cited by this paper
• Longitudinal association of glycemia and microalbuminuria: the Framingham Offspring Study.

  2002cited by this paper
• Albuminuria and Risk of Cardiovascular Events , Death , and Heart Failure in Diabetic and Nondiabetic Individuals

  2002cited by this paper
• PREVEND STUDY GROUP OBESITY AND TARGET ORGAN DAMAGE: THE KIDNEY

  2002cited by this paper
• Effects of aggressive blood pressure control in normotensive type 2 diabetic patients on albuminuria, retinopathy and strokes.

  2002cited by this paper
• Obesity and target organ damage: the kidney

  2002cited by this paper
• Factors Related to the Occurrence of Microalbuminuria During Antihypertensive Treatment in Essential Hypertension

  2002cited by this paper
• Increase in nocturnal blood pressure and progression to microalbuminuria in type 1 diabetes.

  2002cited by this paper
• Microalbuminuria in essential hypertension: redefining the threshold.

  2002cited by this paper
• Excessive Urinary Albumin Levels Are Associated With Future Cardiovascular Mortality in Postmenopausal Women

  2001cited by this paper
• Non-diabetic microalbuminuria, endothelial dysfunction and cardiovascular disease

  2001cited by this paper
• Albuminuria and risk of cardiovascular events, death, and heart failure in diabetic and nondiabetic individuals.

  2001cited by this paper
• Frequency and determinants of microalbuminuria in mild hypertension: a primary-care-based study

  2001cited by this paper
• Smoking Is Related to Albuminuria and Abnormal Renal Function in Nondiabetic Persons

  2000cited by this paper
• Influence of the I/D polymorphism of the angiotensin-converting enzyme gene on the outcome of microalbuminuria in essential hypertension.

  2000cited by this paper
• Microalbuminuria and peripheral arterial disease are independent predictors of cardiovascular and all-cause mortality, especially among hypertensive subjects: five-year follow-up of the Hoorn Study.

  1999cited by this paper
• Urinary albumin excretion. An independent predictor of ischemic heart disease.

  1999cited by this paper
• Microalbuminuria predicts cardiovascular events and renal insufficiency in patients with essential hypertension

  1998cited by this paper
• Microalbuminuria in essential hypertension.

  1998cited by this paper
• Metabolic Risk Factors Worsen Continuously across the Spectrum of Nondiabetic Glucose Tolerance: The Framingham Offspring Study

  1998cited by this paper
• Angiotensin converting enzyme gene I/D polymorphism in essential hypertension and nephroangiosclerosis.

  1998cited by this paper
• Renal protection by antihypertensive drugs: insights from microalbuminuria studies

  1998cited by this paper
• Hyperinsulinemia as a determinant of microalbuminuria in essential hypertension

  1997cited by this paper
• Effect of 14 years of antihypertensive treatment on renal function and urinary albumin excretion in primary hypertension.

  1996cited by this paper
• Elevated serum insulin levels in patients with essential hypertension and microalbuminuria.

  1994cited by this paper
• Factors related to the presence of microalbuminuria in essential hypertension.

  1994cited by this paper
• Long-term influences of antihypertensive therapy on microalbuminuria in essential hypertension.

  1994cited by this paper
• Microalbuminuria Precedes the Development of NIDDM

  1994cited by this paper
• Ambulatory blood pressure and microalbuminuria in essential hypertension: role of circadian variability

  1994cited by this paper
• Microalbuminuria in essential hypertension. Reduction by different antihypertensive drugs.

  1993cited by this paper
• Differences in urinary albumin excretion rate between normotensive and hypertensive, white and nonwhite subjects.

  1992cited by this paper
• Microalbuminuria in essential hypertension.

  1990cited by this paper
• Microalbuminuria as predictor of increased mortality in elderly people.

  1990cited by this paper
• Microalbuminuria. Potential marker for increased cardiovascular risk factors in nondiabetic subjects?

  1990cited by this paper
• Microalbuminuria and casual and ambulatory blood pressure monitoring in normotensives and in patients with borderline and mild essential hypertension.

  1989cited by this paper
• Microalbuminuria as predictor of vascular disease in non-diabetic subjects. Islington Diabetes Survey.

  1988cited by this paper
• Microalbuminuria predicts clinical proteinuria and early mortality in maturity-onset diabetes.

  1984cited by this paper

• Development and Validation of Prediction Models for Hypertensive Nephropathy, the PANDORA Study

  2022cites this paper
• Hypertension in Women: A South-Asian Perspective

  2022cites this paper
• Interaction effect of blood glucose and pressure on the risk of chronic kidney disease: a population-based prospective cohort study

  2022cites this paper
• An Observational Registry to Assess Urinary Albumin Evolution in Saudi Hypertensive Patients with the Current Treatment Local algorithm: Results of the RATIONAL Study

  2020cites this paper
• Hypertension and Target Organ Damage

  2019cites this paper
• Lower Diastolic Blood Pressure was Associated with Higher Incidence of Chronic Kidney Disease in the General Population Only in those Using Antihypertensive Medications

  2019cites this paper
• Is Hypertension-Related Target Organ Damage Reversible/Preventable?

  2018cites this paper
• Inverse correlation between serum adiponectin level and albuminuria in pregnancy-induced hypertension patients

  2018cites this paper
• Bidirectional and Temporal Association Between Hypertension and Microalbuminuria: A Longitudinal Study in Chinese Adults

  2018cites this paper
• Hypertension and hyperglycemia and the combination thereof enhances the incidence of chronic kidney disease (CKD) in middle-aged and older males

  2017cites this paper
• Predictive modeling using a nationally representative database to identify patients at risk of developing microalbuminuria

  2016cites this paper
• Independent Determinants of Urinary Albumin Excretion and Confounding Variables in Type 2 Diabetic Patient

  2016cites this paper
• 22. Chronic Kidney Disease

  2016cites this paper
• Study of ambulatory blood pressure in diabetic children: prediction of early renal insult

  2015cites this paper
• study of ambulatory blood pressure in diabetic children: prediction of early renal insult

  2015cites this paper
• Proteinuria-Microalbuminuria in Renal Damage

  2015cites this paper
• Predictors of Microalbuminuria among Hyperuricemia with Hypertension Patients

  2015cites this paper
• A Single Initiating Cause of Hypertension; Potential for Primary Prevention

  2014cites this paper
• The prevalence and risk factors of microalbuminuria in hypertensive patients under current medical treatment.

  2014cites this paper
• Urinary Albumin to Creatinine Ratio and Incidence of Metabolic Syndrome in Korean population

  2014cites this paper
• Prognostic Value of Microalbuminuria During Antihypertensive Treatment in Essential Hypertension

  2014cites this paper
• High-normal diastolic blood pressure is a risk for development of microalbuminuria in the general population: the Watari study

  2013cites this paper
• Regression of left ventricular hypertrophy and microalbuminuria changes during antihypertensive treatment

  2013cites this paper
• Pre-hypertension as a significant predictor of chronic kidney disease in a general population: the Ohasama Study.

  2012cites this paper
• Marcadores bioquímicos de lesión endotelial, sistema fibrinolítico y microalbuminuria en HTA esencial

  2011cites this paper
• Premenopausal Women Have Increased Risk of Hypertensive Target Organ Damage Compared with Men of Similar Age

  2011cites this paper
• [Nephroprotection diabetes mellitus type 2: lessons from the ADVANCE trial].

  2011cites this paper
• Relationship of Microalbuminuria with different Clinical and Biochemical Parameters in Newly Detected Diabetes Mellitus Cases

  2010cites this paper
• Detection of Left Ventricular Hypertrophy by Different Electrocardiographic Criteria in Clinical Practice. Findings From the Sara Study

  2010cites this paper
• Relationship between increased arterial stiffness and other markers of target organ damage.

  2010cites this paper
• Urine Albumin Excretion, Within Normal Range, Reflects Increasing Prevalence of Metabolic Syndrome in Patients With Essential Hypertension

  2010cites this paper
• Predictors of incident albuminuria in the Framingham Offspring cohort.

  2010cites this paper
• Microalbuminuria as a risk factor: the influence of renin–angiotensin system blockade

  2010cites this paper
• Chapter 20Kidney Disease

  2010cites this paper
• Uso de espironolactona o doxazosina en pacientes con hipertensión arterial refractaria

  2009cites this paper
• Potential link of microalbuminuria with metabolic syndrome in patients undergoing coronary angiography.

  2009cites this paper
• Association between serum uric acid, metabolic syndrome and microalbuminuria in previously untreated essential hypertensive patients.

  2009cites this paper
• Spironolactone and doxazosin treatment in patients with resistant hypertension.

  2009cites this paper
• Uso de espironolactona o doxazosina en pacientes con hipertensión arterial refractaria

  2009cites this paper
• Determinants of urinary albumin excretion within the normal range in patients with type 2 diabetes: the Randomised Olmesartan and Diabetes Microalbuminuria Prevention (ROADMAP) study

  2009cites this paper
• Microalbuminuria and obesity: impact on cardiovascular disease and mortality

  2009cites this paper
• An α-adrenergic blocker titrated by self-measured blood pressure recordings lowered blood pressure and microalbuminuria in patients with morning hypertension: the Japan Morning Surge-1 Study

  2008cites this paper
• [Spironolactone in patients with resistant hypertension].

  2008cites this paper
• Relación de la cistatina C con otros parámetros de riesgo vascular en pacientes con hipertensión arterial

  2008cites this paper
• Relation of albuminuria to left ventricular mass (from the HyperGEN Study).

  2008cites this paper
• Respuesta antihipertensiva a la espironolactona en pacientes con hipertensión arterial refractaria

  2008cites this paper
• [Cystatin C and other cardiovascular markers in hypertension].

  2008cites this paper
• Arterial Hypertension Determined by Ambulatory Blood Pressure Profiles

  2008cites this paper
• Eficacia de una estrategia basada en ARA-II en el tratamiento de pacientes hipertensos con síndrome metabólico

  2008cites this paper
• Can Failure of Vascular Access for Hemodialysis be Predicted by the Initial Blood Flow Measurement

  2008cites this paper
• [New definition of metabolic syndrome: does it have the same cardiovascular risk?].

  2007cites this paper
• Control de las cifras de presión arterial en los pacientes hipertensos con hipertrofia ventricular: estudio VIIDA

  2007cites this paper
• Differential Impacts of Adiponectin on Low‐Grade Albuminuria Between Obese and Nonobese Persons Without Diabetes

  2007cites this paper
• Microalbuminuria screening in patients with hypertension: recommendations for clinical practice

  2007cites this paper
• [Blood pressure control in hypertensive patients with left ventricular hypertrophy. The VIIDA Study].

  2007cites this paper
• Efficacy of indapamide SR compared with enalapril in elderly hypertensive patients with type 2 diabetes.

  2007cites this paper
• Control de las cifras de presión arterial en los pacientes hipertensos con hipertrofia ventricular: estudio VIIDA

  2007cites this paper
• Microalbuminuria and the metabolic syndrome and its components in the Chinese population

  2007cites this paper
• Nueva definicin del sndrome metablico: mismo riesgo cardiovascular?

  2007cites this paper
• [Left ventricular hypertrophy in the Spanish hypertensive population. The ERIC-HTA study].

  2006cites this paper
• Diabetes Efficacy of Indapamide SR Compared With Enalapril in Elderly Hypertensive Patients With Type 2 Diabetes

  2006cites this paper
• Development of microalbuminuria in essential hypertension

  2006cites this paper
• Brachial-Ankle Pulse Wave Velocity Is an Independent Risk Factor for Microalbuminuria in Patients with Essential Hypertension—A Japanese Trial on the Prognostic Implication of Pulse Wave Velocity (J-TOPP)

  2006cites this paper
• Glomerulosclerosis nodular diabética sin diabetes mellitus conocida previamente

  2006cites this paper
• The Japan Morning Surge-1 (JMS-1) Study: Protocol Description

  2006cites this paper
• Hipertrofia ventricular izquierda en la población hipertensa española: Estudio ERIC-HTA

  2006cites this paper
• Determinants of urinary albumin excretion reduction in essential hypertension: a long-term follow-up study

  2006cites this paper
• Waist circumference and the metabolic syndrome predict the development of elevated albuminuria in non-diabetic subjects: the DESIR Study

  2006cites this paper
• Microalbuminuria, blood pressure load, and systemic vascular permeability in primary hypertension.

  2006cites this paper
• Measurement of microalbuminuria--what the nephrologist should know.

  2006cites this paper
• Urinary albumin excretion: lowering the threshold of risk in hypertension.

  2005cites this paper